Regencell Bioscience Holdings Limited's Cash & cash equivalent grew by 189.82 % in the Q4 2026 sequentially, faster than Current Liabilities, this led to improvement in Regencell Bioscience Holdings Limited's Quick Ratio to 10.75, above Regencell Bioscience Holdings Limited average Quick Ratio.

Within Legal Cannabis industry Regencell Bioscience Holdings Limited booked the highest Quick Ratio than Regencell Bioscience Holdings Limited in the fourth quarter 2026. While Quick Ratio total ranking in the fourth quarter 2026 has deteriorated compared to the prior quarter from 431 to 483.

Explain Quick Ratio?
How much Cash & cash equivalents RGC�s has?
What are RGC�s Current Liabilities?

Select the Comparisons :

None ▼

Select the Ratio:

Quick Ratio ▼

None ▼

Quick Ratio ▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/RGC/financial-strength

https://api.csimarket.com/api/v1/companies/RGC/fundamentals

https://api.csimarket.com/api/v1/companies/RGC/fundamentals?mode=as_of&as_of=YYYY-MM-DD

Programmatic access for models, analytics, and integration workflows.

Explore the Financial Data API

Financial API Point-in-Time Financial Fundamentals API API Server API Docs API Discovery

Connect Your AI Assistant

How to Connect Your AI Assistant to CSIMarket MCP MCP Server

Access this full dataset via API

Free sample Full docs All endpoints

RGC Quick Ratio	(Jun 30 2026) Q4	(Jun 30 2025) Q3	0 Q2	0 Q1	0 Q4
Y / Y Current Liabilities Change	98.99 %	Subscribe	Subscribe	Subscribe	Subscribe
Y / Y Cash & cash equivalent Change	189.82 %	Subscribe	Subscribe	Subscribe	Subscribe
Quick Ratio MRQ	10.75	Subscribe	Subscribe	Subscribe	Subscribe
RGC's Total Ranking	# 483	Subscribe	Subscribe	Subscribe	Subscribe
Seq. Current Liabilities Change	98.99 %	Subscribe	Subscribe	Subscribe	Subscribe
Seq. Cash & cash equivalent Change	189.82 %	Subscribe	Subscribe	Subscribe	Subscribe

Quick Ratio fourth quarter 2026 Company Ranking
Within:	No.
Legal Cannabis Industry	# 1
Consumer Non Cyclical Sector	# 6
Overall Market	# 483

Quick Ratio Statistics
High	Average	Low
63.52	7.15	0.01
(Jun 30 2024)		0

Financial Statements
Regencell Bioscience Holdings Limited's Current Liabilities	$ 1 Millions	Visit RGC's Balance sheet
Regencell Bioscience Holdings Limited's Cash & cash equivalent	$ 14 Millions	Visit RGC's Balance sheet
Source of RGC's Sales		Visit RGC's Sales by Geography

Cumulative Regencell Bioscience Holdings Limited's Quick Ratio

RGC's Quick Ratio for the trailling 12 Months

RGC Quick Ratio	(Jun 30 2026) 12 Months	(Jun 30 2025) 12 Months	0 12 Months	0 12 Months	0 12 Months
Y / Y Current Liabilities TTM Growth	38.48 %	Subscribe	Subscribe	Subscribe	Subscribe
Y / Y Cash & cash equivalent TTM Growth	-11.23 %	Subscribe	Subscribe	Subscribe	Subscribe
Quick Ratio TTM	11.52	Subscribe	Subscribe	Subscribe	Subscribe
Total Ranking TTM	# 2904	Subscribe	Subscribe	Subscribe	Subscribe
Seq. Current Liabilities TTM Growth	31.04 %	Subscribe	Subscribe	Subscribe	Subscribe
Seq. Cash & cash equivalent TTM Growth	41.04 %	Subscribe	Subscribe	Subscribe	Subscribe

Quick ratio ranking by company, industry and sector >> Back to RGC Financial Strength Comparisons >> Go to Compare RGC Quick Ratio to its Competitors

On the trailing twelve months basis RGC Cash & cash equivalent more than doubled by 189.82 % in Q4 2026 year on year, faster than Current Liabilities, this led to increase in in Regencell Bioscience Holdings Limited's Quick Ratio to 11.52, above RGC average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Legal Cannabis industry 14 other companies have achieved higher Quick Ratio than Regencell Bioscience Holdings Limited. While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the fourth quarter 2025 from 2823 to 2904.

Explain Quick Ratio?
How much Cash & cash equivalents RGC�s has?
What are RGC�s Current Liabilities?

TTM Quick Ratio Company Ranking
Within:	No.
Within the Legal Cannabis Industry	# 15
Consumer Non Cyclical Sector	# 119
Within the Market	# 2904

trailing twelve months Quick Ratio Statistics
High	Average	Low
15.3	3.57	0.01
(Jun 30 2024)		(Jun 30 2021)

Companies with similar Quick Ratio in the quarter ending Jun 30 2026, within Legal Cannabis Industry	Quick Ratio	Jun 30 2026 MRQ Cash & cash equivalent	Jun 30 2026 MRQ Current Liabilities
Cronos Group Inc	14.14	$ 797.019 Millions	$ 56.364 Millions
Regencell Bioscience Holdings Limited	10.75	$ 14.192 Millions	$ 1.321 Millions
Definium Therapeutics Inc	6.89	$ 1,083.879 Millions	$ 157.204 Millions

Date modified: 2026-07-07T13:05:37+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.